Research ArticleClinical Studies
Reduced Dose of Salvage-line Regorafenib Monotherapy for Metastatic Colorectal Cancer in Japan
GEN HIRANO, AKITAKA MAKIYAMA, CHINATSU MAKIYAMA, TAITO ESAKI, HISANOBU ODA, KEITA UCHINO, MASATO KOMODA, RISA TANAKA, YUZO MATSUSHITA, KENJI MITSUGI, YOSHIHIRO SHIBATA, HOZUMI KUMAGAI, SHUJI ARITA, HIROSHI ARIYAMA, HITOSHI KUSABA, KOICHI AKASHI and EISHI BABA
Anticancer Research January 2015, 35 (1) 371-377;
GEN HIRANO
1Department of Hematology and Oncology, Japan Community Health Care Organization Kyushu Hospital, Kitakyushu, Japan
AKITAKA MAKIYAMA
1Department of Hematology and Oncology, Japan Community Health Care Organization Kyushu Hospital, Kitakyushu, Japan
CHINATSU MAKIYAMA
1Department of Hematology and Oncology, Japan Community Health Care Organization Kyushu Hospital, Kitakyushu, Japan
TAITO ESAKI
2Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center, Fukuoka, Japan
HISANOBU ODA
2Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center, Fukuoka, Japan
KEITA UCHINO
3Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
MASATO KOMODA
3Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
RISA TANAKA
4Department of Oncology, Hamanomachi Hospital, Fukuoka, Japan
YUZO MATSUSHITA
4Department of Oncology, Hamanomachi Hospital, Fukuoka, Japan
KENJI MITSUGI
4Department of Oncology, Hamanomachi Hospital, Fukuoka, Japan
YOSHIHIRO SHIBATA
5Department of Chemotherapy, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
HOZUMI KUMAGAI
6Department of Hematology and Oncology of Kyushu University Hospital, Fukuoka, Japan
SHUJI ARITA
6Department of Hematology and Oncology of Kyushu University Hospital, Fukuoka, Japan
7Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
HIROSHI ARIYAMA
6Department of Hematology and Oncology of Kyushu University Hospital, Fukuoka, Japan
HITOSHI KUSABA
6Department of Hematology and Oncology of Kyushu University Hospital, Fukuoka, Japan
KOICHI AKASHI
6Department of Hematology and Oncology of Kyushu University Hospital, Fukuoka, Japan
EISHI BABA
7Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
In this issue
Anticancer Research
Vol. 35, Issue 1
January 2015
Reduced Dose of Salvage-line Regorafenib Monotherapy for Metastatic Colorectal Cancer in Japan
GEN HIRANO, AKITAKA MAKIYAMA, CHINATSU MAKIYAMA, TAITO ESAKI, HISANOBU ODA, KEITA UCHINO, MASATO KOMODA, RISA TANAKA, YUZO MATSUSHITA, KENJI MITSUGI, YOSHIHIRO SHIBATA, HOZUMI KUMAGAI, SHUJI ARITA, HIROSHI ARIYAMA, HITOSHI KUSABA, KOICHI AKASHI, EISHI BABA
Anticancer Research Jan 2015, 35 (1) 371-377;
Reduced Dose of Salvage-line Regorafenib Monotherapy for Metastatic Colorectal Cancer in Japan
GEN HIRANO, AKITAKA MAKIYAMA, CHINATSU MAKIYAMA, TAITO ESAKI, HISANOBU ODA, KEITA UCHINO, MASATO KOMODA, RISA TANAKA, YUZO MATSUSHITA, KENJI MITSUGI, YOSHIHIRO SHIBATA, HOZUMI KUMAGAI, SHUJI ARITA, HIROSHI ARIYAMA, HITOSHI KUSABA, KOICHI AKASHI, EISHI BABA
Anticancer Research Jan 2015, 35 (1) 371-377;
Jump to section
Related Articles
- No related articles found.
Cited By...
- A Systematic Review and Meta-analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer
- The real-world use of regorafenib for metastatic colorectal cancer: multicentre analysis of treatment pattern and outcomes in Hong Kong
- Efficacy and Safety of TAS-102 in Clinical Practice of Salvage Chemotherapy for Metastatic Colorectal Cancer